Health Care

Satellos Bioscience: Toronto‑listed biotech pushing skeletal muscle regeneration, Phase 1 SAT‑3247 data at World Muscle Society, promising stock outlook.

Discover how Cresco Labs’ new Sunnyside Tamarac dispensary expands Florida’s cannabis market and boosts its vertical‑integration strategy.

Avadel Pharmaceuticals sees institutional surge—BlackRock, Vanguard, and more stake up to 6.72%—sparking takeover‑panel filings and hinting at a possible strategic move that could unlock hidden value.

Henan Lingrui Pharmaceutical’s senior‑management resignations spark new analyst scrutiny as the 600285 stock stays flat amid leadership changes.

Zhende Medical’s first extraordinary general meeting reveals its high‑growth vision, a 66‑P/E valuation and global wound‑care strategy that investors and healthcare professionals closely monitor for future upside.

Trulieve Cannabis Corp: stock dips amid regulatory uncertainty, but medical‑cannabis focus keeps investors hopeful for future growth.

FDA rejects Vanda’s HETLIOZ® jet‑lag application, citing insufficient real‑world evidence, but the company remains poised to address concerns and seek approval.

Integer Holdings faces a 2026 securities‑fraud class action. Learn how the lawsuit and earnings warning could impact share price and what shareholders must do before the Feb 9 deadline.

Explore Erasca Inc.’s volatile stock, analyst “overweight” support, and upcoming J.P. Morgan Healthcare Conference to gauge future upside and risks.

Akanda Corp, a medicinal‑grade cannabis cultivator, faces volatility yet eyes U.S. regulatory shifts for growth.